To develop a new drug, a comprehensive team of experts is needed!

For NovoBioJect, alongside its three female co-founders, an international team of pharma industry veterans and KOLs make up the Amplio Pharma team.

​​

"We firmly believe that with the current team, the effort to amplify the efficacy and safety of the cornerstone treatment of autoimmune diseases like rheumatoid arthritits, is in the most capable hands possible."

- M. Mensonides, co-founder and CEO Amplio Pharma